Financials Diagnostic Medical Systems
Equities
ALDMS
FR0012202497
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 EUR | 0.00% | +4.63% | -8.37% |
18/04 | Diagnostic Medical Systems S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
09/02 | Rhythm Biosciences Seeks to Raise AU$6.6 Million Via Rights Offer; Shares Fall 29% | MT |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 23.37 | 11.51 | 19.83 | 28.37 | 19.67 | 16.28 |
Enterprise Value (EV) 1 | 25.02 | 17.08 | 28.17 | 41.51 | 31.34 | 27.26 |
P/E ratio | -9.04 x | -2.13 x | -6.39 x | -5.33 x | -5.08 x | -2.39 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.77 x | 0.42 x | 0.58 x | 0.81 x | 0.49 x | 0.44 x |
EV / Revenue | 0.82 x | 0.62 x | 0.82 x | 1.18 x | 0.78 x | 0.74 x |
EV / EBITDA | -7.7 x | -3.61 x | -8.23 x | -14.1 x | -65.6 x | -4.32 x |
EV / FCF | -7.2 x | -8.45 x | -21.3 x | -8.54 x | -9.64 x | -2.99 x |
FCF Yield | -13.9% | -11.8% | -4.7% | -11.7% | -10.4% | -33.5% |
Price to Book | 1 x | 0.64 x | 1.35 x | 1.67 x | 1.05 x | 1.04 x |
Nbr of stocks (in thousands) | 16,121 | 16,121 | 16,121 | 16,121 | 16,121 | 16,121 |
Reference price 2 | 1.450 | 0.7140 | 1.230 | 1.760 | 1.220 | 1.010 |
Announcement Date | 30/04/18 | 01/08/19 | 20/05/20 | 31/05/21 | 29/04/22 | 28/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 30.41 | 27.6 | 34.16 | 35.24 | 39.99 | 37.06 |
EBITDA 1 | -3.249 | -4.731 | -3.423 | -2.954 | -0.478 | -6.305 |
EBIT 1 | -3.585 | -5.08 | -3.797 | -3.57 | -0.905 | -6.859 |
Operating Margin | -11.79% | -18.4% | -11.12% | -10.13% | -2.26% | -18.51% |
Earnings before Tax (EBT) 1 | -2.113 | -5.453 | -3.238 | -5.535 | -4.127 | -6.639 |
Net income 1 | -2.544 | -5.4 | -3.105 | -5.24 | -3.875 | -6.82 |
Net margin | -8.37% | -19.56% | -9.09% | -14.87% | -9.69% | -18.4% |
EPS 2 | -0.1604 | -0.3350 | -0.1926 | -0.3300 | -0.2404 | -0.4231 |
Free Cash Flow 1 | -3.474 | -2.021 | -1.326 | -4.858 | -3.249 | -9.123 |
FCF margin | -11.42% | -7.32% | -3.88% | -13.79% | -8.13% | -24.62% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 30/04/18 | 01/08/19 | 20/05/20 | 31/05/21 | 29/04/22 | 28/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.65 | 5.57 | 8.35 | 13.1 | 11.7 | 11 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -0.5066 x | -1.177 x | -2.438 x | -4.446 x | -24.41 x | -1.741 x |
Free Cash Flow 1 | -3.47 | -2.02 | -1.33 | -4.86 | -3.25 | -9.12 |
ROE (net income / shareholders' equity) | -8.19% | -26.5% | -19.8% | -34.7% | -22% | -34.5% |
ROA (Net income/ Total Assets) | -4.98% | -8.26% | -6.15% | -5.18% | -1.14% | -8.02% |
Assets 1 | 51.13 | 65.41 | 50.45 | 101.1 | 338.5 | 85.05 |
Book Value Per Share 2 | 1.460 | 1.120 | 0.9100 | 1.060 | 1.160 | 0.9700 |
Cash Flow per Share 2 | 0.2600 | 0.0700 | 0.0900 | 0.1100 | 0.2600 | 0.2700 |
Capex 1 | 3.28 | 3.36 | 3.38 | 3.08 | 5.88 | 2.6 |
Capex / Sales | 10.78% | 12.18% | 9.88% | 8.75% | 14.71% | 7% |
Announcement Date | 30/04/18 | 01/08/19 | 20/05/20 | 31/05/21 | 29/04/22 | 28/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-8.37% | 19.56M | |
-5.77% | 14.68B | |
-40.71% | 2.71B | |
-12.92% | 2.44B | |
-8.78% | 1.51B | |
-.--% | 1.12B | |
+40.66% | 518M | |
+91.79% | 502M | |
+11.68% | 239M | |
+1.67% | 183M |
- Stock Market
- Equities
- ALDMS Stock
- Financials Diagnostic Medical Systems